1. Home
  2. Labeler Index
  3. Dolgencorp, Inc. (dollar General & Rexall)
  4. 55910-253
  5. NDC Package Code: 55910-253-25 Womans Laxative

NDC Package 55910-253-25 Womans Laxative

Bisacodyl Tablet, Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55910-253-25
Package Description:
25 BLISTER PACK in 1 CARTON / 1 TABLET, COATED in 1 BLISTER PACK
Product Code:
55910-253
Proprietary Name:
Womans Laxative
Non-Proprietary Name:
Bisacodyl
Substance Name:
Bisacodyl
Usage Information:
Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.
11-Digit NDC Billing Format:
55910025325
NDC to RxNorm Crosswalk:
  • RxCUI: 308753 - bisacodyl 5 MG Delayed Release Oral Tablet
  • RxCUI: 308753 - bisacodyl 5 MG Enteric Coated Oral Tablet
    • Product Type:
    Human Otc Drug
    Labeler Name:
    Dolgencorp, Inc. (dollar General & Rexall)
    Dosage Form:
    Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • BISACODYL 5 mg/1
    • Pharmacologic Class(es):
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Stimulant Laxative - [EPC] (Established Pharmacologic Class)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    part334
    Marketing Category:
    OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
    Start Marketing Date:
    06-30-2018
    End Marketing Date:
    06-30-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55910-253-25?

    The NDC Packaged Code 55910-253-25 is assigned to a package of 25 blister pack in 1 carton / 1 tablet, coated in 1 blister pack of Womans Laxative, a human over the counter drug labeled by Dolgencorp, Inc. (dollar General & Rexall). The product's dosage form is tablet, coated and is administered via oral form.

    Is NDC 55910-253 included in the NDC Directory?

    Yes, Womans Laxative with product code 55910-253 is active and included in the NDC Directory. The product was first marketed by Dolgencorp, Inc. (dollar General & Rexall) on June 30, 2018.

    What is the 11-digit format for NDC 55910-253-25?

    The 11-digit format is 55910025325. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255910-253-255-4-255910-0253-25